Home > Insider Trading > Filing (0001179110-14-003409)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130598	Onconova Therapeutics Inc.	ONTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1290208	B Michael Hoffman	712 Fifth Avenue, 36Th Floor New York NY 10019		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-20	71,740	$8.03	4,446,535	No	4	P	Indirect	By the Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2014-02-21	71,740	$8.91	4,518,275	No	4	P	Indirect	By the Michael and Jane Hoffman 2013 Descendants Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By the Michael and Jane Hoffman 2013 Descendants Trust
No	4	P	Indirect	By the Michael and Jane Hoffman 2013 Descendants Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	84,530	Indirect	By the Michael and Jane Hoffman 2013 Descendants Trust(non-GST Exempt Trust)

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased, pursuant to a 10b5-1 plan, in multiple transactions at prices ranging from $7.76 to $8.72, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased, pursuant to a 10b5-1 plan, in multiple transactions at prices ranging from $8.56 to $9.16, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
These shares are held in trust for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.